Synergy Pharma Defends Ch. 11 Sale Plan After Objections
Synergy Pharmaceuticals Inc. is defending its efforts to sell the business to Bausch Health Cos. Inc. in Chapter 11 for approximately $200 million, telling a New York bankruptcy court Wednesday that...To view the full article, register now.
Already a subscriber? Click here to view full article